Company Profile
Monograph Capital is an investment firm focused on the life sciences sector, specifically targeting companies that create new or improved therapeutics, diagnostics, and related technology-enabled business services. The firm aims to enhance healthcare outcomes through its investments.
With primary offices located in London, San Francisco, and Dallas-Fort Worth, Monograph Capital bridges opportunities across North America, the United Kingdom, and Europe. This geographical presence allows the firm to leverage deep experience, relationships, and capabilities to help life sciences companies scale effectively.
The Monograph team comprises individuals with decades of experience in biomedical research and clinical medicine, complemented by over 55 years of cumulative investing experience in the healthcare industry. This extensive background enables Monograph to actively contribute to the growth of nascent organizations into promising biotechnology and related life sciences businesses.
Monograph Capital routinely identifies investment opportunities that have the potential to lead to transformational healthcare outcomes.
News & Signals (0)
No linked news activity found for this company.